25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Oncoclinicas do Brasil
Buy, Hold or Sell?

Let's analyze Oncoclinicas do Brasil together

I guess you are interested in Oncoclinicas do Brasil. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oncoclinicas do Brasil. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Oncoclinicas do Brasil

I send you an email if I find something interesting about Oncoclinicas do Brasil.

1. Quick Overview

1.1. Quick analysis of Oncoclinicas do Brasil (30 sec.)










1.2. What can you expect buying and holding a share of Oncoclinicas do Brasil? (30 sec.)

How much money do you get?

How much money do you get?
R$0.01
When do you have the money?
1 year
How often do you get paid?
94.4%

What is your share worth?

Current worth
R$6.57
Expected worth in 1 year
R$8.76
How sure are you?
72.2%

+ What do you gain per year?

Total Gains per Share
R$2.27
Return On Investment
63.3%

For what price can you sell your share?

Current Price per Share
R$3.59
Expected price per share
R$0 - R$5.17
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Oncoclinicas do Brasil (5 min.)




Live pricePrice per Share (EOD)
R$3.59
Intrinsic Value Per Share
R$-14.08 - R$-16.67
Total Value Per Share
R$-7.51 - R$-10.10

2.2. Growth of Oncoclinicas do Brasil (5 min.)




Is Oncoclinicas do Brasil growing?

Current yearPrevious yearGrowGrow %
How rich?$714.7m$451.3m$71.5m13.7%

How much money is Oncoclinicas do Brasil making?

Current yearPrevious yearGrowGrow %
Making money$8.3m$6.2m$2m24.9%
Net Profit Margin3.4%2.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Oncoclinicas do Brasil (5 min.)




2.4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Oncoclinicas do Brasil?

Welcome investor! Oncoclinicas do Brasil's management wants to use your money to grow the business. In return you get a share of Oncoclinicas do Brasil.

First you should know what it really means to hold a share of Oncoclinicas do Brasil. And how you can make/lose money.

Speculation

The Price per Share of Oncoclinicas do Brasil is R$3.59. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oncoclinicas do Brasil.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oncoclinicas do Brasil, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is R$6.57. Based on the TTM, the Book Value Change Per Share is R$0.55 per quarter. Based on the YOY, the Book Value Change Per Share is R$0.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is R$0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oncoclinicas do Brasil.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 R$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per Share
Usd Eps0.000.0%0.010.4%0.010.3%0.000.0%0.000.0%
Usd Book Value Change Per Share0.4011.2%0.092.6%0.030.9%0.061.7%0.061.7%
Usd Dividend Per Share0.000.0%0.000.1%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share0.4011.2%0.102.7%0.030.9%0.071.8%0.071.8%
Usd Price Per Share1.06-1.70-1.32-1.05-1.05-
Price to Earnings Ratio296.08-121.65-45.06-39.07-39.07-
Price-to-Total Gains Ratio2.64--308.19-5.09--92.26--92.26-
Price to Book Ratio0.94-2.21-1.84-1.53-1.53-
Price-to-Total Gains Ratio2.64--308.19-5.09--92.26--92.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.61748
Number of shares1619
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.090.06
Usd Total Gains Per Share0.100.07
Gains per Quarter (1619 shares)158.23105.30
Gains per Year (1619 shares)632.92421.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12361062315406411
2461220125630813832
369183018894512191253
492244025225916251674
5115305031557420322095
6138366037888924382516
71614270442110428442937
81844880505411932513358
92075490568713436573779
102306100632014940634200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%11.07.00.061.1%11.07.00.061.1%11.07.00.061.1%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%10.05.03.055.6%10.05.03.055.6%10.05.03.055.6%
Dividend per Share3.00.01.075.0%11.00.01.091.7%17.00.01.094.4%17.00.01.094.4%17.00.01.094.4%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%13.05.00.072.2%13.05.00.072.2%13.05.00.072.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Oncoclinicas do Brasil compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.3390.548+327%0.185+1162%0.365+541%0.365+541%
Book Value Per Share--6.5674.804+37%4.147+58%2.917+125%2.917+125%
Current Ratio--1.9681.609+22%1.565+26%1.424+38%1.424+38%
Debt To Asset Ratio--0.6570.696-6%0.674-3%0.582+13%0.582+13%
Debt To Equity Ratio--2.0862.671-22%2.602-20%2.357-12%2.357-12%
Dividend Per Share--0.0040.021-82%0.009-59%0.013-72%0.013-72%
Eps--0.0050.076-93%0.057-91%-0.002+132%-0.002+132%
Free Cash Flow Per Share---0.399-0.174-56%-0.100-75%-0.143-64%-0.143-64%
Free Cash Flow To Equity Per Share--3.2320.790+309%0.104+3015%0.303+966%0.303+966%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---16.668--------
Intrinsic Value_10Y_min---14.080--------
Intrinsic Value_1Y_max---0.822--------
Intrinsic Value_1Y_min---0.807--------
Intrinsic Value_3Y_max---3.116--------
Intrinsic Value_3Y_min---2.962--------
Intrinsic Value_5Y_max---6.190--------
Intrinsic Value_5Y_min---5.690--------
Market Cap2271726956.160-72%3910660888.3206250413094.560-37%4848776546.400-19%3867068480.000+1%3867068480.000+1%
Net Profit Margin--0.0020.034-94%0.029-93%-0.011+602%-0.011+602%
Operating Margin--0.1380.128+8%0.139-1%0.092+49%0.092+49%
Operating Ratio--0.8620.873-1%0.858+0%0.915-6%0.915-6%
Pb Ratio0.547-72%0.9412.212-57%1.841-49%1.534-39%1.534-39%
Pe Ratio171.996-72%296.083121.651+143%45.060+557%39.066+658%39.066+658%
Price Per Share3.590-72%6.1809.878-37%7.663-19%6.111+1%6.111+1%
Price To Free Cash Flow Ratio-2.247+42%-3.869-3.283-15%4.957-178%2.247-272%2.247-272%
Price To Total Gains Ratio1.532-72%2.638-308.188+11783%5.088-48%-92.261+3598%-92.261+3598%
Quick Ratio--2.4781.667+49%1.712+45%1.691+47%1.691+47%
Return On Assets--0.0000.005-95%0.005-94%-0.003+1042%-0.003+1042%
Return On Equity--0.0010.021-96%0.017-95%-0.010+1209%-0.010+1209%
Total Gains Per Share--2.3430.568+312%0.194+1105%0.378+520%0.378+520%
Usd Book Value--714706096.000522821090.000+37%451315874.000+58%317445082.444+125%317445082.444+125%
Usd Book Value Change Per Share--0.4020.094+327%0.032+1162%0.063+541%0.063+541%
Usd Book Value Per Share--1.1290.826+37%0.713+58%0.502+125%0.502+125%
Usd Dividend Per Share--0.0010.004-82%0.002-59%0.002-72%0.002-72%
Usd Eps--0.0010.013-93%0.010-91%0.000+132%0.000+132%
Usd Free Cash Flow---43464056.000-18920688.000-56%-10863907.000-75%-15558967.111-64%-15558967.111-64%
Usd Free Cash Flow Per Share---0.069-0.030-56%-0.017-75%-0.025-64%-0.025-64%
Usd Free Cash Flow To Equity Per Share--0.5560.136+309%0.018+3015%0.052+966%0.052+966%
Usd Market Cap390737036.460-72%672633672.7911075071052.264-37%833989565.981-19%665135778.560+1%665135778.560+1%
Usd Price Per Share0.617-72%1.0631.699-37%1.318-19%1.051+1%1.051+1%
Usd Profit--567944.0008312846.000-93%6240891.000-91%728639.778-22%728639.778-22%
Usd Revenue--269632360.000252069870.000+7%216435426.000+25%165698885.111+63%165698885.111+63%
Usd Total Gains Per Share--0.4030.098+312%0.033+1105%0.065+520%0.065+520%
 EOD+3 -5MRQTTM+20 -15YOY+17 -185Y+26 -910Y+26 -9

3.3 Fundamental Score

Let's check the fundamental score of Oncoclinicas do Brasil based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15171.996
Price to Book Ratio (EOD)Between0-10.547
Net Profit Margin (MRQ)Greater than00.002
Operating Margin (MRQ)Greater than00.138
Quick Ratio (MRQ)Greater than12.478
Current Ratio (MRQ)Greater than11.968
Debt to Asset Ratio (MRQ)Less than10.657
Debt to Equity Ratio (MRQ)Less than12.086
Return on Equity (MRQ)Greater than0.150.001
Return on Assets (MRQ)Greater than0.050.000
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Oncoclinicas do Brasil based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.670
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Oncoclinicas do Brasil

Oncoclínicas do Brasil Serviços Médicos S.A. provides healthcare services focused on oncology, hematology, and radiotherapy in Latin America. It offers diagnosis and treatment services, such as pathological analysis, cryotherapy, palliative care, delife, hilotherapy, molecular journey, laser therapy, integrative medicine, myelogram-bone marrow biopsy, OC care line, OC precision medicine, oncoACCESS, survivorship, telemedicine, genetic testing, personalized medicine and individualized treatment, and veinviewer. The company also provides services in the areas of chemotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter salinization and heparinization, and non-oncological infusions. The company was founded in 2010 and is based in São Paulo, Brazil.

Fundamental data was last updated by Penke on 2024-11-10 11:38:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Oncoclinicas do Brasil earns for each R$1 of revenue.

  • Above 10% is considered healthy but always compare Oncoclinicas do Brasil to the Medical Care Facilities industry mean.
  • A Net Profit Margin of 0.2% means that R$0.00 for each R$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oncoclinicas do Brasil:

  • The MRQ is 0.2%. The company is not making a profit/loss.
  • The TTM is 3.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM3.4%-3.2%
TTM3.4%YOY2.9%+0.5%
TTM3.4%5Y-1.1%+4.5%
5Y-1.1%10Y-1.1%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%4.1%-3.9%
TTM3.4%3.2%+0.2%
YOY2.9%2.5%+0.4%
5Y-1.1%3.2%-4.3%
10Y-1.1%3.5%-4.6%
4.3.1.2. Return on Assets

Shows how efficient Oncoclinicas do Brasil is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oncoclinicas do Brasil to the Medical Care Facilities industry mean.
  • 0.0% Return on Assets means that Oncoclinicas do Brasil generated R$0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oncoclinicas do Brasil:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.5%-0.5%
TTM0.5%YOY0.5%+0.1%
TTM0.5%5Y-0.3%+0.8%
5Y-0.3%10Y-0.3%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%1.1%-1.1%
TTM0.5%1.1%-0.6%
YOY0.5%0.5%0.0%
5Y-0.3%1.0%-1.3%
10Y-0.3%1.0%-1.3%
4.3.1.3. Return on Equity

Shows how efficient Oncoclinicas do Brasil is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oncoclinicas do Brasil to the Medical Care Facilities industry mean.
  • 0.1% Return on Equity means Oncoclinicas do Brasil generated R$0.00 for each R$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oncoclinicas do Brasil:

  • The MRQ is 0.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM2.1%-2.0%
TTM2.1%YOY1.7%+0.4%
TTM2.1%5Y-1.0%+3.1%
5Y-1.0%10Y-1.0%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%2.8%-2.7%
TTM2.1%2.8%-0.7%
YOY1.7%1.8%-0.1%
5Y-1.0%2.3%-3.3%
10Y-1.0%2.6%-3.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Oncoclinicas do Brasil.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Oncoclinicas do Brasil is operating .

  • Measures how much profit Oncoclinicas do Brasil makes for each R$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oncoclinicas do Brasil to the Medical Care Facilities industry mean.
  • An Operating Margin of 13.8% means the company generated R$0.14  for each R$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oncoclinicas do Brasil:

  • The MRQ is 13.8%. The company is operating less efficient.
  • The TTM is 12.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ13.8%TTM12.8%+1.0%
TTM12.8%YOY13.9%-1.1%
TTM12.8%5Y9.2%+3.5%
5Y9.2%10Y9.2%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ13.8%6.6%+7.2%
TTM12.8%6.6%+6.2%
YOY13.9%7.8%+6.1%
5Y9.2%7.2%+2.0%
10Y9.2%7.7%+1.5%
4.3.2.2. Operating Ratio

Measures how efficient Oncoclinicas do Brasil is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are R$0.86 for each R$1 in net sales.

Let's take a look of the Operating Ratio trends of Oncoclinicas do Brasil:

  • The MRQ is 0.862. The company is less efficient in keeping operating costs low.
  • The TTM is 0.873. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.862TTM0.873-0.010
TTM0.873YOY0.858+0.014
TTM0.8735Y0.915-0.042
5Y0.91510Y0.9150.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8620.998-0.136
TTM0.8731.041-0.168
YOY0.8580.990-0.132
5Y0.9150.986-0.071
10Y0.9150.980-0.065
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Oncoclinicas do Brasil.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Oncoclinicas do Brasil is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.97 means the company has R$1.97 in assets for each R$1 in short-term debts.

Let's take a look of the Current Ratio trends of Oncoclinicas do Brasil:

  • The MRQ is 1.968. The company is able to pay all its short-term debts. +1
  • The TTM is 1.609. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.968TTM1.609+0.359
TTM1.609YOY1.565+0.045
TTM1.6095Y1.424+0.186
5Y1.42410Y1.4240.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9681.238+0.730
TTM1.6091.264+0.345
YOY1.5651.316+0.249
5Y1.4241.390+0.034
10Y1.4241.426-0.002
4.4.3.2. Quick Ratio

Measures if Oncoclinicas do Brasil is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oncoclinicas do Brasil to the Medical Care Facilities industry mean.
  • A Quick Ratio of 2.48 means the company can pay off R$2.48 for each R$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oncoclinicas do Brasil:

  • The MRQ is 2.478. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.667. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.478TTM1.667+0.811
TTM1.667YOY1.712-0.045
TTM1.6675Y1.691-0.024
5Y1.69110Y1.6910.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4780.728+1.750
TTM1.6670.816+0.851
YOY1.7121.033+0.679
5Y1.6911.119+0.572
10Y1.6911.168+0.523
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Oncoclinicas do Brasil.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Oncoclinicas do Brasil assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oncoclinicas do Brasil to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.66 means that Oncoclinicas do Brasil assets are financed with 65.7% credit (debt) and the remaining percentage (100% - 65.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oncoclinicas do Brasil:

  • The MRQ is 0.657. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.696. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.657TTM0.696-0.039
TTM0.696YOY0.674+0.021
TTM0.6965Y0.582+0.114
5Y0.58210Y0.5820.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6570.529+0.128
TTM0.6960.517+0.179
YOY0.6740.524+0.150
5Y0.5820.538+0.044
10Y0.5820.527+0.055
4.5.4.2. Debt to Equity Ratio

Measures if Oncoclinicas do Brasil is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oncoclinicas do Brasil to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 208.6% means that company has R$2.09 debt for each R$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oncoclinicas do Brasil:

  • The MRQ is 2.086. The company is just not able to pay all its debts with equity.
  • The TTM is 2.671. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.086TTM2.671-0.585
TTM2.671YOY2.602+0.069
TTM2.6715Y2.357+0.314
5Y2.35710Y2.3570.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0860.987+1.099
TTM2.6710.987+1.684
YOY2.6020.994+1.608
5Y2.3571.107+1.250
10Y2.3571.208+1.149
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every R$1 in earnings Oncoclinicas do Brasil generates.

  • Above 15 is considered overpriced but always compare Oncoclinicas do Brasil to the Medical Care Facilities industry mean.
  • A PE ratio of 296.08 means the investor is paying R$296.08 for every R$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oncoclinicas do Brasil:

  • The EOD is 171.996. Based on the earnings, the company is expensive. -2
  • The MRQ is 296.083. Based on the earnings, the company is expensive. -2
  • The TTM is 121.651. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD171.996MRQ296.083-124.086
MRQ296.083TTM121.651+174.432
TTM121.651YOY45.060+76.591
TTM121.6515Y39.066+82.585
5Y39.06610Y39.0660.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD171.99614.926+157.070
MRQ296.08314.230+281.853
TTM121.65113.916+107.735
YOY45.06012.159+32.901
5Y39.06616.683+22.383
10Y39.06621.204+17.862
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oncoclinicas do Brasil:

  • The EOD is -2.247. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.869. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.283. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.247MRQ-3.869+1.621
MRQ-3.869TTM-3.283-0.586
TTM-3.283YOY4.957-8.240
TTM-3.2835Y2.247-5.530
5Y2.24710Y2.2470.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-2.2478.718-10.965
MRQ-3.8698.926-12.795
TTM-3.2836.929-10.212
YOY4.9577.635-2.678
5Y2.2476.379-4.132
10Y2.2476.595-4.348
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Oncoclinicas do Brasil is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 0.94 means the investor is paying R$0.94 for each R$1 in book value.

Let's take a look of the Price to Book Ratio trends of Oncoclinicas do Brasil:

  • The EOD is 0.547. Based on the equity, the company is cheap. +2
  • The MRQ is 0.941. Based on the equity, the company is cheap. +2
  • The TTM is 2.212. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.547MRQ0.941-0.394
MRQ0.941TTM2.212-1.271
TTM2.212YOY1.841+0.371
TTM2.2125Y1.534+0.678
5Y1.53410Y1.5340.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD0.5471.717-1.170
MRQ0.9411.936-0.995
TTM2.2121.978+0.234
YOY1.8412.168-0.327
5Y1.5342.431-0.897
10Y1.5342.826-1.292
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in BRL. All numbers in thousands.

Summary
Total Assets12,105,380
Total Liabilities7,950,112
Total Stockholder Equity3,811,758
 As reported
Total Liabilities 7,950,112
Total Stockholder Equity+ 3,811,758
Total Assets = 12,105,380

Assets

Total Assets12,105,380
Total Current Assets4,994,177
Long-term Assets7,111,203
Total Current Assets
Cash And Cash Equivalents 550,587
Short-term Investments 1,736,783
Net Receivables 2,263,192
Inventory 271,060
Other Current Assets 172,555
Total Current Assets  (as reported)4,994,177
Total Current Assets  (calculated)4,994,177
+/-0
Long-term Assets
Property Plant Equipment 1,313,130
Goodwill 2,674,579
Intangible Assets 1,805,721
Long-term Assets Other 274,373
Long-term Assets  (as reported)7,111,203
Long-term Assets  (calculated)6,067,803
+/- 1,043,400

Liabilities & Shareholders' Equity

Total Current Liabilities2,537,507
Long-term Liabilities5,412,605
Total Stockholder Equity3,811,758
Total Current Liabilities
Short-term Debt 928,256
Short Long Term Debt 867,814
Accounts payable 951,896
Other Current Liabilities 542,268
Total Current Liabilities  (as reported)2,537,507
Total Current Liabilities  (calculated)3,290,234
+/- 752,727
Long-term Liabilities
Long term Debt 4,300,550
Capital Lease Obligations 412,815
Long-term Liabilities Other 76,169
Long-term Liabilities  (as reported)5,412,605
Long-term Liabilities  (calculated)4,789,534
+/- 623,071
Total Stockholder Equity
Common Stock3,838,647
Retained Earnings -51,980
Accumulated Other Comprehensive Income 127,635
Other Stockholders Equity -102,544
Total Stockholder Equity (as reported)3,811,758
Total Stockholder Equity (calculated)3,811,758
+/-0
Other
Capital Stock2,454,716
Cash and Short Term Investments 2,287,370
Common Stock Shares Outstanding 581,248
Current Deferred Revenue115,087
Liabilities and Stockholders Equity 12,105,380
Net Debt 5,030,592
Net Invested Capital 8,980,122
Net Working Capital 2,456,670
Property Plant and Equipment Gross 1,854,884
Short Long Term Debt Total 5,581,179



6.2. Balance Sheets Structured

Currency in BRL. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
3,362,658
3,321,802
3,114,436
4,970,302
6,032,410
6,281,620
6,414,165
7,274,493
8,219,779
8,267,257
8,556,572
8,609,701
9,181,154
9,765,882
12,105,380
12,105,3809,765,8829,181,1548,609,7018,556,5728,267,2578,219,7797,274,4936,414,1656,281,6206,032,4104,970,3023,114,4363,321,8023,362,658000
   > Total Current Assets 
447,346
0
0
1,412,255
1,368,519
1,084,646
2,639,278
2,871,229
2,541,447
2,341,287
2,092,815
2,826,829
2,778,960
2,838,252
2,688,720
3,105,442
3,195,913
4,994,177
4,994,1773,195,9133,105,4422,688,7202,838,2522,778,9602,826,8292,092,8152,341,2872,541,4472,871,2292,639,2781,084,6461,368,5191,412,25500447,346
       Cash And Cash Equivalents 
-447,346
0
0
740,788
693,447
358,808
1,773,521
536,838
549,915
500,625
112,985
263,208
409,757
550,424
550,516
550,704
412,767
550,587
550,587412,767550,704550,516550,424409,757263,208112,985500,625549,915536,8381,773,521358,808693,447740,78800-447,346
       Short-term Investments 
894,692
0
0
46,206
1,574,194
346,243
-39,559
1,477,914
932,830
560,673
478,442
829,594
362,881
186,906
40,142
210,718
0
1,736,783
1,736,7830210,71840,142186,906362,881829,594478,442560,673932,8301,477,914-39,559346,2431,574,19446,20600894,692
       Net Receivables 
0
0
0
563,331
614,029
644,105
746,341
762,861
893,208
1,123,399
1,315,979
1,522,216
1,798,593
1,856,823
1,880,955
2,064,073
2,422,387
2,263,192
2,263,1922,422,3872,064,0731,880,9551,856,8231,798,5931,522,2161,315,9791,123,399893,208762,861746,341644,105614,029563,331000
       Other Current Assets 
0
0
0
24,469
19,983
28,915
64,041
24,285
50,575
47,284
53,249
47,874
56,285
114,479
85,607
73,559
106,523
172,555
172,555106,52373,55985,607114,47956,28547,87453,24947,28450,57524,28564,04128,91519,98324,469000
   > Long-term Assets 
-447,346
0
0
1,950,403
1,953,283
2,029,790
2,331,024
3,161,181
3,740,173
4,072,878
5,181,678
5,392,950
5,488,297
5,718,320
5,920,981
6,075,712
6,569,969
7,111,203
7,111,2036,569,9696,075,7125,920,9815,718,3205,488,2975,392,9505,181,6784,072,8783,740,1733,161,1812,331,0242,029,7901,953,2831,950,40300-447,346
       Property Plant Equipment 
0
0
0
614,415
605,627
589,148
627,297
729,068
848,884
940,918
1,047,078
1,090,605
1,088,257
1,140,456
1,178,508
1,235,082
1,280,879
1,313,130
1,313,1301,280,8791,235,0821,178,5081,140,4561,088,2571,090,6051,047,078940,918848,884729,068627,297589,148605,627614,415000
       Goodwill 
0
0
0
612,818
616,293
606,777
843,389
1,168,973
1,642,523
1,806,714
2,608,776
2,564,448
2,599,287
2,586,655
2,566,447
2,669,970
2,670,969
2,674,579
2,674,5792,670,9692,669,9702,566,4472,586,6552,599,2872,564,4482,608,7761,806,7141,642,5231,168,973843,389606,777616,293612,818000
       Intangible Assets 
0
0
0
595,829
595,405
650,620
658,438
1,069,436
1,077,390
1,157,270
1,280,617
1,350,016
1,380,533
1,487,227
1,509,851
4,190,604
1,792,829
1,805,721
1,805,7211,792,8294,190,6041,509,8511,487,2271,380,5331,350,0161,280,6171,157,2701,077,3901,069,436658,438650,620595,405595,829000
       Long-term Assets Other 
-447,346
0
0
109,337
11,028
68,763
85,203
1,600,923
1,058,813
685,505
613,667
959,681
496,878
302,243
136,318
87,649
190,808
274,373
274,373190,80887,649136,318302,243496,878959,681613,667685,5051,058,8131,600,92385,20368,76311,028109,33700-447,346
> Total Liabilities 
0
0
0
2,685,352
2,631,195
2,893,270
2,948,963
3,727,467
3,930,401
4,114,096
4,729,886
5,587,323
5,717,774
5,787,400
5,960,814
6,501,783
7,090,778
7,950,112
7,950,1127,090,7786,501,7835,960,8145,787,4005,717,7745,587,3234,729,8864,114,0963,930,4013,727,4672,948,9632,893,2702,631,1952,685,352000
   > Total Current Liabilities 
0
0
0
1,013,906
858,800
939,911
1,107,007
1,190,722
1,275,694
1,170,860
1,476,735
1,883,279
1,629,053
1,736,240
1,816,769
1,816,458
2,498,409
2,537,507
2,537,5072,498,4091,816,4581,816,7691,736,2401,629,0531,883,2791,476,7351,170,8601,275,6941,190,7221,107,007939,911858,8001,013,906000
       Short-term Debt 
0
0
0
272,376
157,845
301,376
325,373
393,377
375,021
255,827
408,817
402,995
509,428
409,103
460,551
474,249
891,519
928,256
928,256891,519474,249460,551409,103509,428402,995408,817255,827375,021393,377325,373301,376157,845272,376000
       Short Long Term Debt 
0
0
0
241,876
126,384
0
299,513
355,910
336,000
207,788
350,764
338,825
427,938
325,089
390,470
407,030
828,186
867,814
867,814828,186407,030390,470325,089427,938338,825350,764207,788336,000355,910299,5130126,384241,876000
       Accounts payable 
0
0
0
345,686
370,385
308,386
373,607
427,339
409,450
337,014
483,695
604,785
531,273
721,132
803,109
795,396
889,500
951,896
951,896889,500795,396803,109721,132531,273604,785483,695337,014409,450427,339373,607308,386370,385345,686000
       Other Current Liabilities 
0
0
0
96,640
35,917
207,579
34,073
91,246
79,390
112,835
90,428
310,828
144,764
121,262
98,424
455,759
633,239
542,268
542,268633,239455,75998,424121,262144,764310,82890,428112,83579,39091,24634,073207,57935,91796,640000
   > Long-term Liabilities 
0
0
0
1,671,446
1,772,395
1,953,359
1,841,956
2,536,745
2,654,707
2,943,236
3,253,151
3,704,044
4,088,721
4,051,160
4,144,045
4,685,325
4,592,369
5,412,605
5,412,6054,592,3694,685,3254,144,0454,051,1604,088,7213,704,0443,253,1512,943,2362,654,7072,536,7451,841,9561,953,3591,772,3951,671,446000
       Long term Debt Total 
0
0
0
0
1,459,938
1,272,671
1,244,312
2,034,437
2,053,127
2,201,863
2,575,132
3,071,177
3,336,598
3,227,387
0
0
0
0
00003,227,3873,336,5983,071,1772,575,1322,201,8632,053,1272,034,4371,244,3121,272,6711,459,9380000
       Other Liabilities 
0
0
0
0
0
677,717
594,673
494,630
598,539
741,345
666,484
632,867
748,786
817,780
0
0
0
0
0000817,780748,786632,867666,484741,345598,539494,630594,673677,71700000
> Total Stockholder Equity
656,371
0
0
399,839
406,248
-52,724
1,734,179
1,854,009
1,826,448
1,801,421
2,014,187
2,117,785
2,022,039
2,230,114
2,214,997
2,301,226
2,300,485
3,811,758
3,811,7582,300,4852,301,2262,214,9972,230,1142,022,0392,117,7852,014,1871,801,4211,826,4481,854,0091,734,179-52,724406,248399,83900656,371
   Common Stock
0
0
0
416,066
421,405
425,656
2,207,134
2,207,134
2,207,134
2,207,134
2,249,716
2,249,716
2,249,716
2,454,716
2,454,716
2,338,647
2,338,647
3,838,647
3,838,6472,338,6472,338,6472,454,7162,454,7162,249,7162,249,7162,249,7162,207,1342,207,1342,207,1342,207,134425,656421,405416,066000
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 
556,699
0
0
273,557
-15,157
18,773
9,524
106,714
102,146
109,813
301,239
340,423
236,550
241,077
120,367
131,156
120,722
127,635
127,635120,722131,156120,367241,077236,550340,423301,239109,813102,146106,7149,52418,773-15,157273,55700556,699
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
99,672
0
0
0
277,108
0
-132,435
-125,087
-125,087
-125,087
-177,162
-183,862
-197,919
-220,377
-219,773
-103,703
-103,602
-102,544
-102,544-103,602-103,703-219,773-220,377-197,919-183,862-177,162-125,087-125,087-125,087-132,4350277,10800099,672



6.3. Balance Sheets

Currency in BRL. All numbers in thousands.




6.4. Cash Flows

Currency in BRL. All numbers in thousands.




6.5. Income Statements

Currency in BRL. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in BRL. All numbers in thousands.

Gross Profit (+$)
totalRevenue5,488,776
Cost of Revenue-3,560,200
Gross Profit1,928,5761,928,576
 
Operating Income (+$)
Gross Profit1,928,576
Operating Expense-1,172,069
Operating Income756,507756,507
 
Operating Expense (+$)
Research Development37
Selling General Administrative1,172,069
Selling And Marketing Expenses0
Operating Expense1,172,0691,172,106
 
Net Interest Income (+$)
Interest Income23,231
Interest Expense-559,788
Other Finance Cost-736
Net Interest Income-537,293
 
Pretax Income (+$)
Operating Income756,507
Net Interest Income-537,293
Other Non-Operating Income Expenses0
Income Before Tax (EBT)314,1651,198,849
EBIT - interestExpense = 196,719
213,574
783,406
Interest Expense559,788
Earnings Before Interest and Taxes (EBIT)756,507873,953
Earnings Before Interest and Taxes (EBITDA)1,013,872
 
After tax Income (+$)
Income Before Tax314,165
Tax Provision--10,044
Net Income From Continuing Ops312,562324,209
Net Income223,618
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,732,269
Total Other Income/Expenses Net-442,342537,293
 

Technical Analysis of Oncoclinicas do Brasil
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oncoclinicas do Brasil. The general trend of Oncoclinicas do Brasil is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oncoclinicas do Brasil's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oncoclinicas do Brasil.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.98 < 5.09 < 5.17.

The bearish price targets are: .

Tweet this
Oncoclinicas do Brasil Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oncoclinicas do Brasil. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oncoclinicas do Brasil Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Moving Average Convergence/Divergence (MACD) ChartOncoclinicas do Brasil Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oncoclinicas do Brasil. The current adx is .

Oncoclinicas do Brasil Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Relative Strength Index (RSI) ChartOncoclinicas do Brasil Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Stochastic Oscillator ChartOncoclinicas do Brasil Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Commodity Channel Index (CCI) ChartOncoclinicas do Brasil Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Chande Momentum Oscillator (CMO) ChartOncoclinicas do Brasil Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Williams %R ChartOncoclinicas do Brasil Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Average True Range (ATR) ChartOncoclinicas do Brasil Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily On-Balance Volume (OBV) ChartOncoclinicas do Brasil Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oncoclinicas do Brasil.

Oncoclinicas do Brasil Daily Money Flow Index (MFI) ChartOncoclinicas do Brasil Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oncoclinicas do Brasil.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Oncoclinicas do Brasil Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oncoclinicas do Brasil based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.670
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Oncoclinicas do Brasil with someone you think should read this too:
  • Are you bullish or bearish on Oncoclinicas do Brasil? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oncoclinicas do Brasil? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oncoclinicas do Brasil

I send you an email if I find something interesting about Oncoclinicas do Brasil.


Comments

How you think about this?

Leave a comment

Stay informed about Oncoclinicas do Brasil.

Receive notifications about Oncoclinicas do Brasil in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.